Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von HC Wainwright 

scPharmaceuticals diskutieren

scPharmaceuticals

WKN: A2H7XD / Symbol: SCPH / Name: scPharmaceuticals / Aktie / Ausrüstung & Versorgung / Small Cap /

4,80 €
-0,04 %

Einschätzung Buy
Rendite (%) -41,00 %
Kursziel 16,53
Veränderung
Endet am 23.03.24

scPharmaceuticals Inc. (NASDAQ: SCPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Ratings data for SCPH provided by MarketBeat

Einschätzung Buy
Rendite (%) -44,32 %
Kursziel 16,45
Veränderung
Endet am 02.08.24

scPharmaceuticals Inc. (NASDAQ: SCPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Ratings data for SCPH provided by MarketBeat

Einschätzung Buy
Rendite (%) -45,73 %
Kursziel 16,41
Veränderung
Endet am 11.08.24

scPharmaceuticals Inc. (NASDAQ: SCPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Ratings data for SCPH provided by MarketBeat

scPharmaceuticals Inc. (NASDAQ: SCPH) is now covered by analysts at Craig Hallum. They set a "buy" rating on the stock.
Ratings data for SCPH provided by MarketBeat

Einschätzung Buy
Rendite (%) -27,85 %
Kursziel 16,57
Veränderung
Endet am 15.05.25

scPharmaceuticals Inc. (NASDAQ: SCPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Ratings data for SCPH provided by MarketBeat

Einschätzung Buy
Rendite (%) -19,57 %
Kursziel 16,30
Veränderung
Endet am 19.08.25

scPharmaceuticals Inc. (NASDAQ: SCPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Ratings data for SCPH provided by MarketBeat

Einschätzung Buy
Rendite (%) 49,75 %
Kursziel 11,37
Veränderung
Endet am 14.11.25

scPharmaceuticals Inc. (NASDAQ: SCPH) had its price target lowered by analysts at Craig Hallum from $16.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for SCPH provided by MarketBeat

Einschätzung Buy
Rendite (%) 49,75 %
Kursziel 17,06
Veränderung
Endet am 14.11.25

scPharmaceuticals Inc. (NASDAQ: SCPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Ratings data for SCPH provided by MarketBeat

Einschätzung Buy
Rendite (%) 47,91 %
Kursziel 17,18
Veränderung
Endet am 03.03.26

scPharmaceuticals Inc. (NASDAQ: SCPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Ratings data for SCPH provided by MarketBeat

Einschätzung Buy
Rendite (%) 68,72 %
Kursziel 16,51
Veränderung
Endet am 20.03.26

scPharmaceuticals Inc. (NASDAQ: SCPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Ratings data for SCPH provided by MarketBeat

Einschätzung Buy
Rendite (%) 70,99 %
Kursziel 11,00
Veränderung
Endet am 20.03.26

scPharmaceuticals Inc. (NASDAQ: SCPH) had its price target lowered by analysts at Maxim Group from $20.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for SCPH provided by MarketBeat